Cargando…
Atropine augments cardiac contractility by inhibiting cAMP-specific phosphodiesterase type 4
Atropine is a clinically relevant anticholinergic drug, which blocks inhibitory effects of the parasympathetic neurotransmitter acetylcholine on heart rate leading to tachycardia. However, many cardiac effects of atropine cannot be adequately explained solely by its antagonism at muscarinic receptor...
Autores principales: | Perera, Ruwan K., Fischer, Thomas H., Wagner, Michael, Dewenter, Matthias, Vettel, Christiane, Bork, Nadja I., Maier, Lars S., Conti, Marco, Wess, Juergen, El-Armouche, Ali, Hasenfuß, Gerd, Nikolaev, Viacheslav O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680190/ https://www.ncbi.nlm.nih.gov/pubmed/29123207 http://dx.doi.org/10.1038/s41598-017-15632-x |
Ejemplares similares
-
Cardiomyocyte Membrane Structure and cAMP Compartmentation Produce Anatomical Variation in β(2)AR-cAMP Responsiveness in Murine Hearts
por: Wright, Peter T., et al.
Publicado: (2018) -
Interactions of Calcium Fluctuations during Cardiomyocyte Contraction with Real-Time cAMP Dynamics Detected by FRET
por: Sprenger, Julia U., et al.
Publicado: (2016) -
Phosphodiesterases and Compartmentation of cAMP and cGMP Signaling in Regulation of Cardiac Contractility in Normal and Failing Hearts
por: Calamera, Gaia, et al.
Publicado: (2022) -
Phosphodiesterases and cAMP Pathway in Pituitary Diseases
por: Bizzi, Mariana Ferreira, et al.
Publicado: (2019) -
Upregulation of Phosphodiesterase 2A Augments T Cell Activation by Changing cGMP/cAMP Cross-Talk
por: Kurelic, Roberta, et al.
Publicado: (2021)